Santiago Arroyo
Director/Board Member en H. LUNDBECK A/S .
Fortuna: 971 100 $ al 31/03/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michael Skynner | M | 55 | 11 años | |
Kevin Lee | M | 55 | 12 años | |
Ganesh Venkataraman Kaundinya | M | 57 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | 4 años |
Amir Faridmoayer | M | - |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
Jose-Carlos Gutiérrez-Ramos | M | 61 | 9 años | |
Dominique Sirena | M | - |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
Alistair Milnes | M | 50 | 3 años | |
Lars Søren Rasmussen | M | 65 | 11 años | |
Jim Smith | M | 64 | 10 años | |
Stephen Sands | M | 67 | - | |
Jeremy Levin | M | 70 | 7 años | |
Jeffrey Berkowitz | M | 58 | 6 años | |
Gregory Winter | M | 73 | 15 años | |
Lene Skole-Sørensen | F | 65 | 9 años | |
Helen Hobbs | M | 71 | 13 años | |
Joseph Echevarria | M | 66 | 9 años | |
Janice Bourque | F | 67 | 5 años | |
Travis Thompson | M | - | 6 años | |
Dorothea Wenzel | M | 55 | 3 años | |
Lars Erik Holmqvist | M | 64 | 9 años | |
Richard Kender | M | 68 | 5 años | |
Shantanu Narayen | M | 60 | 11 años | |
Lars Bang | M | 61 | 36 años | |
Charl van Zyl | M | 57 | 1 años | |
Lasse Skibsbye | M | 41 | 2 años | |
Denis Patrick | M | - | 14 años | |
Zafar Qadir | M | - | 4 años | |
Sonya Weigle | F | - | 3 años | |
Thomas Edward Gibbs | M | 53 | 1 años | |
Tarek Samad | M | - | 3 años | |
Steve Danehy | M | - | 12 años | |
Dorte Clausen | F | 40 | 2 años | |
Hossein Armandi | M | 62 | 2 años | |
Camilla Andersson | F | 52 | 2 años | |
Nicholas Keen | M | 56 | 7 años | |
Thomas Mikkel Mortensen | M | - | - | |
Georges Gemayel | M | 64 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | 2 años |
Keld Flintholm Jørgensen | M | 53 | 5 años | |
Monique Schiersing | M | - |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
David Borah | M | - | 3 años | |
James Sutcliffe | M | 68 | 1 años | |
Pierre Legault | M | 63 | 5 años | |
Palle Holm Olesen | M | - | - | |
Graziano Seghezzi | M | 55 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
Nigel Crockett | M | 59 | 5 años | |
Kush Parmar | M | 42 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | 2 años |
Johan Luthman | M | 65 | 5 años | |
Alethia Young | F | 45 | 1 años | |
Jakob Riis | M | 58 | 1 años | |
Juliane Lenzner | F | - | - | |
Ivan Cheung | M | 47 | 19 años | |
Jörg Hornstein | M | 47 | 2 años | |
Mira Chaurushiya | M | - |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | - |
Philippe Dro | M | 61 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | 2 años |
Jennifer Perry | F | - | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 48 | 48.00% |
Dinamarca | 25 | 25.00% |
Reino Unido | 19 | 19.00% |
Suiza | 9 | 9.00% |
Japón | 2 | 2.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Santiago Arroyo
- Red Personal